Adamas gets $40M in VC funds for flu, neurology work

August 18, 2009

Fierce Biotech: Emeryville, CA-based Adamas Pharmaceuticals has scooped up $40 million in Series D cash to fund a trio of development programs--including work on a combo antiviral therapy for the flu--which has swiftly become one of the hottest fields in biomedical research.

Read the full article here >>